open access

Vol 11, Supp. G (2015)
Case report
Published online: 2015-12-17
Get Citation

Treatment of disseminated neuroendocrine tumor with octreotide in patient with advanced cachexia and limited compliance — case study

Łukasz Hajac

open access

Vol 11, Supp. G (2015)
CASE REPORT
Published online: 2015-12-17

Abstract

Patient age 62 treated for anxiety disorders and other concomitant diseases was diagnosed because of massive weight loss and abdominal pain. Diagnosis resolved as disseminated neuroendocrine neoplasm, originating probably in the intestine. Due to severe cachexia symptomatic treatment was indicated as initial medication, upgrading patients’ overall performance status. Than somatostatin analogue was prescribed. It assured long term stabilization of cancer, even though the treatment was occasionally interrupted by periodic deteriorations in patients’ psychic status.

Abstract

Patient age 62 treated for anxiety disorders and other concomitant diseases was diagnosed because of massive weight loss and abdominal pain. Diagnosis resolved as disseminated neuroendocrine neoplasm, originating probably in the intestine. Due to severe cachexia symptomatic treatment was indicated as initial medication, upgrading patients’ overall performance status. Than somatostatin analogue was prescribed. It assured long term stabilization of cancer, even though the treatment was occasionally interrupted by periodic deteriorations in patients’ psychic status.

Get Citation

Keywords

neuroendocrine tumor, somatostatine analogues, compliance

About this article
Title

Treatment of disseminated neuroendocrine tumor with octreotide in patient with advanced cachexia and limited compliance — case study

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. G (2015)

Article type

Case report

Pages

12-14

Published online

2015-12-17

Keywords

neuroendocrine tumor
somatostatine analogues
compliance

Authors

Łukasz Hajac

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl